GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹515 Cr | ₹456 Cr | ₹387 Cr | ₹354 Cr | ₹355 Cr |
What is the latest Contingent Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹515 Cr |
| Mar2025 | ₹456 Cr |
| Mar2024 | ₹387 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹355 Cr |
How is Contingent Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹515 Cr | 12.92 | |
| Mar2025 | ₹456 Cr | 17.78 | |
| Mar2024 | ₹387 Cr | 9.46 | |
| Mar2023 | ₹354 Cr | -0.26 | |
| Mar2022 | ₹355 Cr | - | |
Compare Contingent Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,771.0 Cr | 0.7% | -9.3% | -3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 0.7% |
-9.3% |
-3.3% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses